Dr. Grossberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1438 S Grand Blvd
Saint Louis, MO 63104Phone+1 314-977-4829Fax+1 314-268-5494
Summary
- Dr. George Grossberg, based in Saint Louis, MO, is a specialist in geriatrics with extensive expertise in dementia, Alzheimer's disease, and long-term acute care. He completed his medical education and residency in psychiatry at Saint Louis University School of Medicine and David P. Wohl Memorial Mental Health Institute, with an internship at Mercy Hospital. Dr. Grossberg has contributed to the field through publications focusing on Alzheimer's disease treatments, particularly monoclonal antibodies, and his work has been cited in related research. He has participated in clinical trials, such as the AC-1204 long-term efficacy study. His professional accolades include being named among America's Top Doctors from Castle Connolly and other honors recognizing his contributions to medicine and healthcare.
Education & Training
- David P. Wohl Memorial Mental Health InstituteResidency, Psychiatry, 1977 - 1979
- SSM Health/Saint Louis University School of MedicineResidency, Psychiatry, 1976 - 1977
- Mercy Hospital (St Louis)Internship, Transitional Year, 1975 - 1976
- Saint Louis University School of MedicineClass of 1975
Certifications & Licensure
- IL State Medical License 1997 - 2026
- MO State Medical License 1976 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- St. Louis Magazine: Top Doctors Castle Connolly, 2001
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Safety concerns associated with BACE1 inhibitors - past, present and future.Aniketh Naidu, Bret Silverglate, Mary Silverglate, George T Grossberg
Expert Opinion on Drug Safety. 2025-02-13 - The impact of cognitive reserve relative to risk of Alzheimer's disease and rate of progression: an up-to-date review of the literature.Jordan Beveridge, Poorva Sheth, Shaan Thakkar, Bret Silverglate, George Grossberg
Expert Review of Neurotherapeutics. 2025-02-01 - Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein.Dominic Antony, Poorva Sheth, Aaron Swenson, Charles Smoller, Kim Maguire
Expert Opinion on Pharmacotherapy. 2025-01-01
Journal Articles
- The Cholinergic System in the Pathophysiology and Treatment of Alzheimer’s DiseaseGeorge T Grossberg, Peter J Snyder, Martin R Farlow, Brain
Press Mentions
- New Data on IV Ketamine for Resistant Depression in the ElderlyMarch 14th, 2023
- LUCIDITY Phase 3 Topline Data Presented at CTAD for HMTM - the Only Oral Anti-Tau Therapy in Late-Stage DevelopmentNovember 30th, 2022
- Avoiding Alzheimer’s: Lifestyle Modifications You Can Make TodaySeptember 22nd, 2022
- Join now to see all
Other Languages
- Hebrew, Hungarian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: